(CIDRAP News) – During the 2009 influenza pandemic, clinicians were frustrated by the lack of useful diagnostic tests, the government had no national system for monitoring stress on healthcare facilities, and there was some duplication in federal media campaigns.
(CIDRAP News) – Clinicians are heeding antiviral prescribing guidance changes made over the past decade because of antiviral resistance and a greater focus on protecting high-risk patients, particularly during the 2009 H1N1 pandemic, researchers reported today.
(CIDRAP News) Federal officials today allowed the public health emergency declaration that was prompted by the H1N1 influenza outbreak last year to lapse, signaling an end to emergency authorizations for certain special uses of antiviral drugs and other items.
(CIDRAP News) An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.
(CIDRAP News) Legal issues that came into play during the H1N1 flu pandemic provided a useful look at how laws can help ease the availability of the vaccine, but in some instances can work against immunization efforts, according to a legal expert who has analyzed events that unfolded over the past year.
(CIDRAP News) In the wake of a pandemic vaccine that came too little and too late to blunt the second wave of pandemic flu infections last fall, President Barack Obama's science advisory group today presented a set of recommendations on how to more quickly produce a vaccine in the face of another novel flu outbreak or other public health emergency.
(CIDRAP News) The World Health Organization's (WHO's) vaccine advisory group recently agreed to keep in place its guidance on pandemic H1N1 vaccines and discussed contamination issues related to the Rotarix rotovirus vaccine.